• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
LB Pharmaceuticals released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1405 (forecast USD -0.57)
04:00
LB Pharmaceuticals released FY2025 9 Months Earnings on November 6, 2025 (EST) with actual revenue of USD 0 and EPS of USD -40.5593
04:00
Oct6
LB Pharmaceuticals' LB-102 Earns Buy Rating, Shows Great Potential
14:07
Sep16
Pontifax Management 4 G.P. (2015) Ltd. Announced Acquisition of LB Pharmaceuticals Inc. Common Stock
20:16
Aug23
LB Pharmaceuticals released FY2025 Semi-Annual earnings on August 22 (EST), actual revenue USD 0, actual EPS USD -40.4187
03:00
LB Pharmaceuticals released FY2025 Q1 earnings on August 22 (EST), actual revenue USD 0, actual EPS USD -20.2093
03:00

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -3.556 M, EPS -0.1405

Sep11
IPO(EST)

Listing Price USD 15

Aug22
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -5.089 M, EPS -20.2093

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More